The Gross Margin of Huakang Biomedical Holdings Co Ltd (8622.HK) is 67.32%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 67.32% |
| 2023-12-31 | 64.49% |
| 2022-12-31 | 66.77% |
| 2021-12-31 | 62.98% |
| 2020-12-31 | 67.00% |
| 2019-12-31 | 70.24% |
| 2018-12-31 | 75.25% |
| 2017-12-31 | 69.83% |
| 2016-12-31 | 69.35% |
| 2015-12-31 | 73.85% |